To make things easier, leave this box checked On shared devices, we recommend that you disconnect from Euroquity when you are done
Email

You will receive an email to define a new password

Location

Select your country

and your language

Hi ,

Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.

% completed

%

medal 2
This profile is validated by 2 label.

Company

Andaman7

Andaman7_logo
50
EQ SCORE

The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.

Andaman7 is a combination of • mobile apps for patients (and individual care providers like doctors, nurses, physiotherapists,...) and • a HIP - Health Intermediation Platform. Customers are pharma companies.

Liège, Région wallonne, Belgium

Send a message

English

Andaman7

English

Andaman7 is a Belgian American startup that has a pretty innovative approach to solving several problems in the healthcare. CEO: Vincent Keunen's (https://www.linkedin.com/in/vincentkeunen) personal story is at the start of the company and is a strong motivator (http://bit.ly/a7vkblogen). Vincent has many years of experience in healthcare with successful health software companies covering 90% of...

See more

Andaman7 is a Belgian American startup that has a pretty innovative approach to solving several problems in the healthcare. CEO: Vincent Keunen's (https://www.linkedin.com/in/vincentkeunen) personal story is at the start of the company and is a strong motivator (http://bit.ly/a7vkblogen). Vincent has many years of experience in healthcare with successful health software companies covering 90% of Belgian hospitals and family doctors (+ 1 exit). The team is pretty experienced (meet the team and investors on our web site).

Andaman7 has both

  • a social goal: free for B2C, empowering people with their health data, while strictly respecting their privacy and
  • an economic goal: B2B customers are pharma doing clinical trials (including phase 4 and outcome based studies, virtual trials, siteless trials...) and hospitals/home care agencies needing remote patient monitoring.

We have a pretty innovative combination of a mobile app for patients and a HIP (Health Intermediation Platform) to allow peer to peer (decentralized/no central authority) exchange of medical data. We will also provide services on top of that with partners. The app is already available in 22 languages. The project is ambitious and global.

We are looking for a few strategic investors to finalize our second seed round. We are also interested in U.S. investors to globalize our business.

  • 6

    Followers

  • 3

    Like

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
454 Entities
ePitches EuroQuity
270 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Members
EUROQUITY BELGIUM
EuroQuity Belgium AT THE SERVICE OF BUSINESS GROWTH The community is reserved for Belgian startups and scaleups and their partners: investors and business advisors.
987 Members

Our history

Start in 2012

  • 2012

    First ideas, pilot development started

  • 2014

    - Company incorporated - Initial capital : 200k€

  • 2015

    - First version on iPad - First version of iPhone - First fund raise from FFF: 1.3M€ vs 500k€ target

  • 2016

    Android version HIP = Health Intermediation Platform API available First hospital fully compatible

  • 2017-2018

    Second fund raise : 3M€ (850k€ signed, 800k€ promised, 1350k€ to go). Corporate partner.

to be continued ...